Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank86
3Y CAGR+45.7%
5Y CAGR+102.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+45.7%/yr
Annual compound
5Y CAGR
+102.4%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
33.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.38M | -14.3% |
| 2024 | $7.45M | +130.9% |
| 2023 | $3.23M | +56.3% |
| 2022 | $2.06M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $188000.00 | +370.0% |
| 2019 | $40000.00 | - |
| 2018 | $0.00 | - |